- Home
- WKSP vs APM Comparison
WKSP vs APM Comparison
Compare WKSP & APM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WKSP
- APM
- Stock Information
- Founded
- WKSP 2003
- APM 2010
- Country
- WKSP United States
- APM United Kingdom
- Employees
- WKSP N/A
- APM N/A
- Industry
- WKSP Auto Parts:O.E.M.
- APM Biotechnology: Pharmaceutical Preparations
- Sector
- WKSP Consumer Discretionary
- APM Health Care
- Exchange
- WKSP Nasdaq
- APM Nasdaq
- Market Cap
- WKSP 17.2M
- APM 18.9M
- IPO Year
- WKSP N/A
- APM 2018
- Fundamental
- Price
- WKSP $2.50
- APM $1.28
- Analyst Decision
- WKSP Strong Buy
- APM
- Analyst Count
- WKSP 3
- APM 0
- Target Price
- WKSP $12.83
- APM N/A
- AVG Volume (30 Days)
- WKSP 248.0K
- APM 110.5K
- Earning Date
- WKSP 11-13-2025
- APM 12-19-2025
- Dividend Yield
- WKSP N/A
- APM N/A
- EPS Growth
- WKSP N/A
- APM N/A
- EPS
- WKSP N/A
- APM N/A
- Revenue
- WKSP $14,286,679.00
- APM N/A
- Revenue This Year
- WKSP $148.41
- APM N/A
- Revenue Next Year
- WKSP $88.10
- APM N/A
- P/E Ratio
- WKSP N/A
- APM N/A
- Revenue Growth
- WKSP 123.37
- APM N/A
- 52 Week Low
- WKSP $1.92
- APM $0.59
- 52 Week High
- WKSP $12.00
- APM $7.49
- Technical
- Relative Strength Index (RSI)
- WKSP 47.54
- APM 42.80
- Support Level
- WKSP $1.95
- APM $1.22
- Resistance Level
- WKSP $2.25
- APM $1.43
- Average True Range (ATR)
- WKSP 0.26
- APM 0.13
- MACD
- WKSP 0.02
- APM 0.00
- Stochastic Oscillator
- WKSP 61.70
- APM 25.45
About WKSP Worksport Ltd.
Worksport Ltd through its subsidiaries, designs, develops, manufactures, and owns the IP on a variety of tonneau covers, solar integrations, and NP (Non-Parasitic), Hydrogen-based true green energy solutions for the sustainable, clean energy, and automotive industries. The company's product includes soft vinyl tonneau covers and hard aluminum tonneau covers. It operates in two reporting segments for financial reporting purposes: Hard Tonneau Covers and Soft Tonneau Covers. Geographically, the company operates in Canada, United States and Other Countries.
About APM Aptorum Group Limited
Aptorum Group Ltd clinical-stage biopharmaceutical company. It is engaged in the discovery, development, and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. The company operates in one segment: research and development. The projects are ALS-4, SACT-1, and RPIDD. It is also engaged in providing healthcare services.